Bacterial compositions for the treatment of cancer

Details for Australian Patent Application No. 2005251397 (hide)

Owner Gunn, H.

Inventors Gunn, Harold David

Agent Davies Collison Cave

Pub. Number AU-B-2005251397

PCT Pub. Number WO2005/120560

Priority 60/577,206 07.06.04 US

Filing date 30 May 2005

Wipo publication date 22 December 2005

Acceptance publication date 11 November 2010

International Classifications

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/116 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent bacterial antigens

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2005/120560 Priority application(s): WO2005/120560

11 November 2010 Application Accepted

  Published as AU-B-2005251397

10 March 2011 Standard Patent Sealed

18 August 2011 Assignment Registered

  Gunn, Harold The patent has been assigned to QU Biologics Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251403-Cationic lipids and methods of use

2005251395-Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins